Company
PreciseDx
Understanding a breast cancer diagnosis in hours, not weeks.
Also known as PreciseDx Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- New York, NY, United States
- Customers
- Oncologists, Surgeons, Pathologists, Payors, Patients
- Legal name
- PreciseDx Inc.
Claim, correct or request removal
Record updated 19 October 2026
About
PreciseBreast® uses OncoIntelligence TM , our proprietary AI-platform, to combine AI-grade with key clinical factors to produce an OncoIntelligence Score TM .
Funding snapshot
- Total raised
- $32MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Undisclosed, $3.7M2026-09-23
Funding rounds
- Round, 2026
- $3.7M2026-09-23, SEC form D sold
- Round, 2025
- $11.2M2025-05-28, SEC form D sold, 9 investors
- Series B
- $20.7M2024-08-21, Company stated
- Round, 2024
- $20.7M2024-02-20, SEC form D sold, 10 investors
Products
- Other
- PreciseBreast®
Loading relationship preview